Browsing by Author Rodríguez, Vanina

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 6 of 6
Issue DateTitleAuthor(s)
11-Jul-2019Daratumumab displays in vitro and in vivo anti-tumor activity in models of B cell non-Hodgkin lymphoma and improves responses to standard chemo-immunotherapy regimensVidal Crespo, Anna; Matas Céspedes, Alba; Rodríguez, Vanina; Rossi, Cédric; Valero, Juan G.; Serrat, Neus; Sanjuan Pla, Alejandra; Menéndez Buján, Pablo; Roué, Gaël; López Guillermo, Armando; Giné Soca, Eva; Campo Güerri, Elias; Colomer Pujol, Dolors; Bezombes, Christine; Lammerts van Bueren, J.; Chiu, Christopher; Doshi, Parul; Pérez Galán, Patricia
6-Dec-2018Development of a novel anti-CD19 chimeric antigen receptor: A paradigm for an affordable CAR T cell production at academic institutionsCastella, Maria; Boronat, Anna; Martín Ibáñez, Raquel; Rodríguez, Vanina; Suñé, Guillermo; Caballero, Miguel; Marzal, Berta; Pérez-Amill, Lorena; Martín-Antonio, Beatriz; Castaño, Julio; Bueno, Clara; Balagué, Olga; González-Navarro, Europa Azucena; Serra Pagès, Carles; Engel Rocamora, Pablo; Vilella, Ramon; Benítez-Ribas, Daniel; Ortiz-Maldonado, Valentín; Cid Vidal, Joan; Tabera, Jaime; Canals i Coll, Josep M.; Lozano, Miquel; Baumann, Tycho; Vilarrodona, Anna; Trias, Esteve; Campo Güerri, Elias; Menéndez Buján, Pablo; Urbano Ispizua, Álvaro; Yagüe, Jordi; Pérez Galán, Patricia; Rives, Susana; Delgado, Julio (Delgado González); Juan, Manel
1-Nov-2019Notch1 signaling in NOTCH1-mutated mantle cell lymphoma depends on Delta-Like ligand 4 and is a potential target for specific antibody therapy.Silkenstedt, Elisabeth; Arenas, Fabian; Colom-Sanmartí, Berta; Xargay i Torrent, Sílvia; Higashi, Morihiro; Giró, Ariadna; Rodríguez, Vanina; Fuentes, Patricia; Aulitzky, Walter E.; Kuip, Heiko van der; Beà Bobet, Sílvia M.; Toribio, María L.; Campo Güerri, Elias; López-Guerra, Mónica; Colomer Pujol, Dolors
1-Apr-2019Pharmacological modulation of CXCR4 cooperates with BET bromodomain inhibition in diffuse large B-cell lymphomaRecasens Zorzo, Clara; Cardesa Salzmann, Teresa; Petazzi, Paolo; Ros Blanco, Laia; Esteve Arenys, Anna; Clot, Guillem; Guerrero Hernández, Martina; Rodríguez, Vanina; Soldini, Davide; Valera Barros, Alexandra; Moros Sanz, Alexandra; Climent, Fina; González Barca, Eva; Mercadal, Santiago; Arenillas Rocha, Leonor; Calvo, Xavier; Mate, José L.; Gutiérrez García, Gonzalo; Casanova Rigat, Isolda; Mangues Bafalluy, Ramon; Sanjuan Pla, Alejandra; Bueno, Clara; Menéndez Buján, Pablo; Martínez, Antonio; Colomer Pujol, Dolors; Estrada Tejedor, Roger; Teixidó, Jordi; Campo Güerri, Elias; López Guillermo, Armando; Borrell, José Ignacio; Colomo Saperas, Lluís; Pérez Galán, Patricia; Roué, Gaël
Oct-2017The BET bromodomain inhibitor CPI203 improves lenalidomide activity in in vitro and in vivo models of multiple myeloma by synergistic blockade of Ikaros and Myc signaling.Díaz Sánchez, Tania; Rodríguez, Vanina; Lozano Garcia, Ester; Mena Jaramillo, Mari Pau; Calderón, Marcos; Rosiñol Dachs, Laura; Martínez, Antonio; Tovar, Natalia; Pérez Galán, Patricia; Bladé, J. (Joan); Roué, Gaël; Fernández de Larrea Rodríguez, Carlos José
8-Jun-2015The splicing modulator sudemycin induces a specific antitumor response and cooperates with ibrutinib in chronic lymphocytic leukemiaXargay i Torrent, Sílvia; López-Guerra, Mónica; Rosich, Laia; Montraveta, Arnau; Roldán, Jocabed; Rodríguez, Vanina; Villamor i Casas, Neus; Aymerich Gregorio, Marta; Lagisetti, Chandraiah; Webb, Thomas R.; López-Otin, Carlos; Campo Güerri, Elias; Colomer Pujol, Dolors